Embolic Protection Devices Market Analysis, Growth and Segment Forecasts to 2022
- Submitted by: Marketreport
- Views: 106
- Category: Other
- Date Submitted: 08/10/2016 03:11 AM
- Pages: 3
- Report this Essay
Technavio Announces the Publication of its Research Report Global Embolic Protection Devices Market 2016-2020
Technavio recognizes the following companies as the key players in the global embolic protection devices market: Abbott Laboratories, Boston Scientific, Cardinal Health, and Medtronic.
Other Prominent Vendors in the market are: Abiomed, Advansource Biomaterials, AGA Medical, Allium Medical, AngioDynamics, AngioSlide, Atrium Medical, Biophan Technologies, Biosense Webster, Cardiac Science, CardiacAssist, Cardica, Cardio-Flow, Claret Medical, Contego Medical, Cook Group, Cryolife, Edward Lifesciences, Innovative Cardiovascular Solutions, Keystone Heart, and Transverse Medical.
Browse full report with TOC@ https://marketreportscenter.com/reports/344090/global-embolic-protection-devices-market-2016-2020
Commenting on the report, an analyst from Technavios team said: Integrated technologies by small companies for market penetration is a key trend for this market. Small companies develop advanced technologies to enter the market. Until date, only a few products are in their development stage or have received regulatory approval only in one region. These products are highly advanced and specific to the preference of physicians. Post approval, these advanced devices can pose a threat to large companies such as Medtronic and Boston Scientific.
According to the report, incidence of cardiac diseases and adoption of PCI is a key driver for this market. The incidence of cardiac diseases is on the rise worldwide. In 2015, the CDC estimated that these diseases caused about 610,000 deaths in the US. The organization also estimates that coronary heart disease was the most common cardiac disease, causing 375,000 deaths in the US annually. To treat these diseases, physicians diagnose and may recommend surgeries based on their stage.
Further, the report states that high cost of stenting is a challenge to market growth. The demand for and use of embolic...
Technavio recognizes the following companies as the key players in the global embolic protection devices market: Abbott Laboratories, Boston Scientific, Cardinal Health, and Medtronic.
Other Prominent Vendors in the market are: Abiomed, Advansource Biomaterials, AGA Medical, Allium Medical, AngioDynamics, AngioSlide, Atrium Medical, Biophan Technologies, Biosense Webster, Cardiac Science, CardiacAssist, Cardica, Cardio-Flow, Claret Medical, Contego Medical, Cook Group, Cryolife, Edward Lifesciences, Innovative Cardiovascular Solutions, Keystone Heart, and Transverse Medical.
Browse full report with TOC@ https://marketreportscenter.com/reports/344090/global-embolic-protection-devices-market-2016-2020
Commenting on the report, an analyst from Technavios team said: Integrated technologies by small companies for market penetration is a key trend for this market. Small companies develop advanced technologies to enter the market. Until date, only a few products are in their development stage or have received regulatory approval only in one region. These products are highly advanced and specific to the preference of physicians. Post approval, these advanced devices can pose a threat to large companies such as Medtronic and Boston Scientific.
According to the report, incidence of cardiac diseases and adoption of PCI is a key driver for this market. The incidence of cardiac diseases is on the rise worldwide. In 2015, the CDC estimated that these diseases caused about 610,000 deaths in the US. The organization also estimates that coronary heart disease was the most common cardiac disease, causing 375,000 deaths in the US annually. To treat these diseases, physicians diagnose and may recommend surgeries based on their stage.
Further, the report states that high cost of stenting is a challenge to market growth. The demand for and use of embolic...